Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Mechanism of Angiogenesis

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...

Regulation of Angiogenesis and Blood Supply

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Wet Transfer of In Situ Grown Azo-Containing Two-Dimensional Conjugated Covalent Organic Framework Films for Photoswitchable Electronic Devices.

Angewandte Chemie (International ed. in English)·2026

Same author

Mulberrofuran A: A Multifunctional 2-Arylbenzofuran Flavonoid-Insights into Pharmacological Actions, Molecular Mechanisms, and Therapeutic Potential.

Molecules (Basel, Switzerland)·2026

Same author

Exploration of the effect and mechanism of <i>Eclipta prostrata L.</i> against gastric cancer based on network pharmacology and experimental verification.

Oncology letters·2026

Same author

Experimental study on the treatment of norepinephrine transporter-overexpressing pheochromocytomas and paragangliomas: a synthetic lethality strategy combining <sup>131</sup>I-MIBG with PARP inhibitors.

Frontiers in oncology·2025

Same author

Solvent-Driven Precise Control of Stacking Configurations in Covalent Organic Frameworks for High-Efficiency Photocatalysis.

Angewandte Chemie (International ed. in English)·2025

Same author

Crocetin, a versatile carotenoid: Novel insights into pharmacological effects, molecular mechanisms, and therapeutic potential.

International immunopharmacology·2025

Search research articles

Related Experiment Video

Updated: Feb 27, 2026

In Vitro Model of Coronary Angiogenesis

In Vitro Model of Coronary Angiogenesis

Published on: March 10, 2020

A novel modified physiologically relevant model for cardiac angiogenesis.

Hao Zhang¹, Jiajun Pan¹, Fan Qiu¹

¹Department of Thoracic Cardiovascular Surgery, Affiliated Hospital of Xuzhou Medical University, Xuzhou 221006, Jiangsu, China.

Microvascular Research

|July 2, 2017

Summary

A novel cardiac explants matrigel assay effectively models myocardial capillary formation. This reliable method assesses angiogenic stimulants and inhibitors for treating ischemic heart diseases.

Keywords:

Angiogenesis Cardiac explants Fibronectin HUVECs Matrigel

More Related Videos

2.5D Model for Ex Vivo Mechanical Characterization of Sprouting Angiogenesis in Living Tissue

2.5D Model for Ex Vivo Mechanical Characterization of Sprouting Angiogenesis in Living Tissue

Published on: February 28, 2025

The Corneal Micropocket Assay: A Model of Angiogenesis in the Mouse Eye

The Corneal Micropocket Assay: A Model of Angiogenesis in the Mouse Eye

Published on: August 16, 2014

Related Experiment Videos

Last Updated: Feb 27, 2026

In Vitro Model of Coronary Angiogenesis

In Vitro Model of Coronary Angiogenesis

Published on: March 10, 2020

2.5D Model for Ex Vivo Mechanical Characterization of Sprouting Angiogenesis in Living Tissue

2.5D Model for Ex Vivo Mechanical Characterization of Sprouting Angiogenesis in Living Tissue

Published on: February 28, 2025

The Corneal Micropocket Assay: A Model of Angiogenesis in the Mouse Eye

The Corneal Micropocket Assay: A Model of Angiogenesis in the Mouse Eye

Published on: August 16, 2014

Area of Science:

Cardiovascular Biology
Regenerative Medicine
Biomedical Engineering

Background:

Cardiac angiogenesis is crucial for understanding and treating ischemic heart diseases.
Existing angiogenesis assays lack consensus and often fail to capture the complexity of in vivo processes.
There is a need for a more physiologically relevant assay to evaluate therapeutic strategies.

Purpose of the Study:

To develop and validate a novel modified cardiac explants matrigel assay for studying cardiac angiogenesis.
To compare the efficacy of this new assay against traditional methods.
To assess the assay's utility in evaluating angiogenic stimulants and inhibitors.

Main Methods:

Development of a modified cardiac explants matrigel assay.
Quantitative image analysis of vascular sprout morphology.
Assessment of explants under normoxia and hypoxia with vascular endothelial growth factor (VEGF) and pigment epithelium-derived factor (PEDF).

Main Results:

The matrigel assay produced longer, more complex vascular sprouts compared to fibronectin.
Vascular sprout morphology in the matrigel assay closely mimics in vivo myocardial capillary formation.
The assay successfully demonstrated the effects of VEGF and PEDF on cardiac angiogenesis under varying oxygen conditions.

Conclusions:

The novel cardiac explants matrigel assay provides a more physiologically relevant and reliable method for studying cardiac angiogenesis.
This assay can be used to assess the efficacy of angiogenic stimulants and inhibitors for potential therapeutic applications in ischemic heart diseases.
The assay's accessibility and reliability make it a valuable tool for pharmacological compound assessment.